Abstract Objective To investigate the effects of obesity on response to therapy and pulmonary function in children with asthma who receive inhaled corticosteroid (ICS) treatment. Methods A total of 129 children with asthma were divided into two groups according to their body mass index: normal weight group (n=64) and obese group (n=65). The asthma control status and pulmonary function were compared between the two groups after one year of ICS treatment. The pulmonary function was expressed as percent forced expiratory volume in 1 second (FEV1%), percent predicted forced vital capacity (FVC%), peak expiratory flow (PEF), peak expiratory flow at 25% of vital capacity (PEF25), and peak expiratory flow at 50% of vital capacity (PEF50). The asthma control status was expressed as complete control rate, partial control rate, and uncontrolled rate. Sixty-eight healthy children were selected as the healthy control group. Results There were significant differences in the indices of pulmonary function between the three groups before treatment (PP25, and PEF50 between the two groups. The complete control rate, partial control rate, and uncontrolled rate in the normal weight group were 72%, 19%, and 9%, respectively, while the rates in the obese group were 28%, 51%, and 22%, respectively; the normal weight group had a significantly better asthma control status than the obese group (PConclusions The asthmatic children with obesity have a significantly less improvement in large airway function and a poorer asthma control status after ICS treatment than those with the normal weight.
Corbo GM, Forastiere F, De Sario M, et al. Wheeze and asthma in children: associations with body mass index, sports, television viewing, and diet[J]. Epidemiology, 2008, 19(5): 747-755.
[3]
Bruske I, Flexeder C, Heinrich J. Body mass index and the incidence of asthma in children[J]. Curr Opin Allergy Clin Immunol, 2014, 14(2): 155-160.
[4]
Borrell LN, Nguyen EA, Roth LA, et al. Childhood obesity and asthma control in the GALA II and SAGE II studies[J]. Am J Respir Crit Care Med, 2013, 187(7): 697-702.
[5]
Juel CT, Ulrik CS. Obesity and asthma: impact on severity, asthma control, and response to therapy[J]. Respir Care, 2013, 58(5): 867-873.
[6]
Frey U, Latzin P, Usemann J, et al. Asthma and obesity in children: current evidence and potential systems biology approaches[J]. Allergy, 2015, 70(1): 26-40.
[7]
Lang JE. Obesity and asthma in children: current and future therapeutic options[J]. Paediatr Drugs, 2014, 16(3): 179-188.
Hampton T. Studies probe links between childhood asthma and obesity[J]. JAMA, 2014, 311(17): 1718-1719.
[10]
Weiss ST, Shore S. Obesity and asthma: directions for research[J]. Am J Respir Crit Care Med, 2004, 169(8): 963-968.
[11]
Hallstrand TS, Fischer ME, Wurfel MM, et al. Genetic pleiotropy between asthma and obesity in a community-based sample of twins[J]. J Allergy Clin Immunol, 2005, 116(6): 1235-1241.
[12]
Los H, Postmus PE, Boomsma DI. Asthma genetics and intermediate phenotypes: a review from twin studies[J].Twin Res, 2001, 4(2): 81-93.
[13]
González JR, Caceres A, Esko T, et al. A common 16p11.2 inversion underlies the joint susceptibility to asthma and obesity[J]. Am J Hum Genet, 2014, 94(3): 361-372.
[14]
Hamid YH, Urhammer SA, Glümer C, et al. The common T60N polymarphism of the lymhotaxin-alpha gene is associated with type 2 diabetes and other phenotypes of the metabolic syndrome[J]. Disbetologia, 2005, 48(3): 445-451.
[15]
Sandford AJ, Pare PD. The genetics of asthma. The important questions[J]. Am J Respir Crit Care Med, 2000, 161(3 Pt 2): S202-S206.
[16]
Clarke JR, Jenkins MA, Hopper JL, et al. Evidence for genetic associations between asthma, atopy, and bronchial hyperresponsiveness: a study of 8-to 18-yr-old twins[J]. Am J Respir Crit Care Med, 2000, 162(6): 2188-2193.
[17]
Haselkorn T, Fish JE, Chipps BE, et al. Effect of weight change on asthma-related health outcomes in patients with severe or difficult-to-treat asthma[J]. Respir Med, 2009, 103(2): 274-283.
[18]
Razi E, Razi A, Moosavi GA. Influence of body mass indexes on response to treatment in acute asthma[J]. Acta Med Iran, 2014, 52(3): 192-196.
[19]
da Rosa GJ, Schivinski CI. Assessment of respiratory muscle strength in children according to the classification of body mass index[J]. Rev Paul Pediatr, 2014, 32(2):250-255.
[20]
Silva Rde C, Assis AM, Goncalves MS, et al. The prevalence of wheezing and its association with body mass index and abdominal obesity in children[J]. J Asthma, 2013, 50(3): 267-273.
[21]
Tavasoli S, Eghtesadi S, Heidarnazhad H, et al. Central obesity and asthma outcomes in adults diagnosed with asthma[J]. J Asthma, 2013, 50(2): 180-187.
[22]
Assad N, Qualls C, Smith LJ, et al. Body mass index is a stronger predictor than the metabolic syndrome for future asthma in women. The longitudinal CARDIA study[J]. Am J Respir Crit Care Med, 2013, 188(3): 319-326.
[23]
Shore SA. Obesity and asthma: possible mechanisms[J]. J Allergy Clin Immunol, 2008, 121(5): 1087-1093.
[24]
Raj D, Kabra SK, Lodha R. Childhood obesity and risk of allergy or asthma[J]. Immunol Allergy Clin North Am, 2014, 34(4): 753-765.
[25]
Gruchała-Niedoszytko M, Malgorzewicz S, Niedoszytko M, et al. The influence of obesity on inflammation and clinical symptoms in asthma[J]. Adv Med Sci, 2013, 58(1): 15-21.
[26]
Jensen ME, Gibson PG, Collins CE, et al. Airway and systemic inflammation in obese children with asthma[J]. Eur Respir J, 2013, 42(4): 1012-1019.
Sood A, Qualls C, Schuyler M, et al. Low serum adiponectin predicts future risk for asthma in women[J]. Am J Respir Crit Care Med, 2012, 186(1): 41-47.
[29]
Paul G, Brehm JM, Alcorn JF. Vitamin D and asthma[J]. Am J Respir Crit Care Med, 2012, 185(2): 124-132.
[30]
Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004[J]. Arch Intern Med, 2009, 169(6): 626-632.
[31]
Brehm JM, Celedón JC, Soto-Quiros ME, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica[J]. Am J Respir Crit Care Med, 2009, 179(9): 765-771.
[32]
Wang YH, Wills-Karp M. The potential role of interleukin-17 in severe asthma[J]. Curr Allergy Asthma Rep, 2011, 11(5): 388-394.
[33]
Young KJ, Jung-Ho S, Jae-Hyun L, et al. Obesity increases airway hyperresponsiveness via the TNF-α pathway and treating obesity induces recovery[J]. PLoS One, 2015, 10(2): e0116540.
[34]
Harskamp-van Ginkel MW, Hill KD, Becker K, et al. Drug dosing and pharmacokinetics in children with obesity: a systematic review[J]. JAMA Pediatr, 2015, 169(7): 678-685.
[35]
Vinding RK, Stokholm J, Chawes BL, et al. Blood lipid levels associate with childhood asthma, airway obstruction, bronchial hyperresponsiveness, and aeroallergen sensitization[J]. Allergy Clin Immunol, 2015, 6749(15): 783-786.
[36]
Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women[J]. N Engl J Med, 2006, 354(22): 2340-2348.
[37]
Serafino-Agrusa L, Spatafora M, Scichilone N. Asthma and metabolic syndrome: current knowledge and future perspectives[J]. World J Clin Cases, 2015, 3(3): 285-292.
[38]
Al-Shawwa BA, Al-Huniti NH, DeMattia L, et al. Asthma and insulin resistance in morbidly obese children and adolescents[J]. Asthma, 2007, 44(6): 469-473.
[39]
Forno E, Han YY, Muzumdar RH, et al. Insulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthma[J]. J Allergy Clin Immunol, 2015, 136(2): 304-311.
[40]
Sánchez Jiménez J, Herrero Espinet FJ, Mengibar Garrido JM, et al. Asthma and insulin resistance in obese children and adolescents[J]. Pediatr Allergy Immunol, 2014, 25(7): 699-705.
